Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A nasal care spray

A technology for sprays and nasal cavities, applied in the field of cleaning agents, can solve the problems of limited performance in dissolving nasal mucus and inability to relieve symptoms, and achieve good bactericidal and antibacterial performance, good continuous dissolving ability, and strong antibacterial ability

Active Publication Date: 2021-10-01
广州蓓思语生物科技有限公司
View PDF11 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the inventor found during the experiment that the surfactant selected by CN200880110989 has limited performance in dissolving nasal mucus, and after dissolving, it can only be maintained for a short time, and cannot achieve long-term symptom relief.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A nasal care spray
  • A nasal care spray
  • A nasal care spray

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0020] A nasal care spray comprises the following components according to weight percentage: 0.22% sodium pyruvate, 0.05% pyruvic acid, 0.05% polyhexamethylene biguanide, 0.1% Gemini surfactant, and the balance is physiological sea water.

[0021] Above-mentioned Gemini surfactant is quaternary ammonium salt cationic surfactant, and structural formula is as follows:

[0022]

[0023] The appearance of this product is transparent liquid, no cytotoxicity in vitro, no intradermal irritation, no delayed hypersensitivity reaction; physical and chemical indicators: pH: 6.0-8.0, heavy metals (calculated as Pb) should be ≤ 20mg / ml; hygienic indicators : The total number of bacterial colonies should be ≤100cfu / ml, the total number of fungal colonies should be ≤10cfu / ml, no coliforms, Pseudomonas aeruginosa and Staphylococcus aureus were detected.

Embodiment 2

[0025] A nasal cavity care spray comprises the following components according to weight percentage: 0.22% sodium pyruvate, 0.05% pyruvic acid, 0.05% polyhexamethylene biguanide, and the balance is physiological sea water.

Embodiment 3

[0027] A nasal care spray comprises the following components according to weight percentage: 0.22% sodium pyruvate, 0.05% pyruvate, 0.05% polyhexamethylene biguanide, 0.1% Tween 80, and the balance is physiological sea water.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a nasal cavity care spray and a use method of the spray. The spray includes the following components according to weight percentage: 0.22% sodium pyruvate, 0.05% pyruvic acid, 0.05% antiseptic, 0.1% Gemini surfactant, and the balance is physiological sea water. The nasal cavity care spray provided by the invention can effectively dissolve nasal mucus, relieve nasal mucus and nasal congestion symptoms, and has strong antibacterial ability, and is used for nasal cavity cleaning of patients with nasal cavity diseases such as acute and chronic rhinitis, allergic rhinitis, nasal polyps, and sinusitis. It can also be used for daily nasal care, nasal cleaning after rhinitis surgery and chemotherapy.

Description

technical field [0001] The invention belongs to the field of cleaning agents, in particular to a nursing spray for cleaning nasal cavity. Background technique [0002] Rhinitis is an inflammatory disease of the nasal cavity, which is the inflammation of the nasal mucosa caused by viruses, bacteria, allergens, various physical and chemical factors, and certain systemic diseases. The main pathological changes of rhinitis are congestion, swelling, exudation, hyperplasia, atrophy or necrosis of nasal mucosa. Clinical symptoms include nasal congestion, nasal discharge, decreased sense of smell, headache, dizziness, etc. People can use oral medicine or drug spray to treat rhinitis, and at the same time, nasal spray can also be used to clean the nasal cavity to relieve some symptoms. [0003] CN2012100521550 discloses a sodium pyruvate nasal spray, its components include sodium pyruvate, pyruvic acid, isotonic regulator, preservative and water, for cleaning and removing harmful po...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/19A61K9/12A61K47/18A61H35/04A61P11/02
CPCA61H35/04A61K9/0043A61K9/12A61K31/19A61K47/186A61P11/02A61K2300/00
Inventor 黄敏郭俊喜
Owner 广州蓓思语生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com